Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemoptysis: methods of localization].

Favre Laurent1, Martina Martins, Alain Sauty

  • 1Service de pneumologie, CHUV, 1011 Lausanne. favre.laurent@chuv.ch

Revue Medicale Suisse
|December 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring.

Molecules (Basel, Switzerland)·2025
Same author

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators.

The journal of allergy and clinical immunology. Global·2024
Same author

Data accuracy, consistency and completeness of the national Swiss cystic fibrosis patient registry: Lessons from an ECFSPR data quality project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
Same author

Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA/R334W genotype.

The European respiratory journal·2022
Same author

[Phage therapy for respiratory infections].

Revue medicale suisse·2022
Same author

Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis.

Respiratory medicine and research·2022

Chest X-rays can locate hemoptysis origins in 20-50% of cases, but computed tomography (CT) scans are more accurate. Bronchoscopy aids diagnosis when imaging is normal, identifying lung cancer in 3% of cases.

Area of Science:

  • Pulmonology
  • Radiology
  • Oncology

Context:

  • Hemoptysis, or coughing up blood, requires accurate localization of the bleeding source for effective diagnosis and treatment.
  • Diagnostic imaging plays a crucial role in identifying the origin of hemoptysis, with varying degrees of success across different modalities.

Purpose:

  • To evaluate the diagnostic accuracy of chest radiography, computed tomography (CT) scans, and bronchoscopy in localizing the source of hemoptysis.
  • To assess the incidence of bronchogenic carcinoma in patients undergoing bronchoscopy for hemoptysis, particularly with normal initial imaging.
  • To determine appropriate diagnostic pathways for hemoptysis based on patient risk factors and initial imaging results.

Summary:

  • Chest radiography localizes hemoptysis in 20-50% of cases; CT scans offer superior accuracy.

Related Experiment Videos

  • Bronchoscopy identifies bleeding sources in 40% of cases with normal imaging, revealing lung cancer in 3%.
  • For minor hemoptysis without lung cancer risk factors, a normal CT scan may suffice; otherwise, radiologic follow-up is recommended, especially for smokers over 50.

    • Impact:

    • Highlights the complementary roles of imaging and bronchoscopy in hemoptysis diagnosis.
    • Informs clinical decision-making regarding the workup of hemoptysis, optimizing resource utilization.
    • Emphasizes the importance of considering lung cancer in specific patient demographics presenting with hemoptysis.